Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY® by the Taiwan Food and Drug Administration for the Treatment of Moderately to Severely Active Ulcerative Colitis 2025-08-14 12:02
KBP's Contest of Injunction Obtained by Novo Nordisk Continues in Arbitration 2025-08-13 09:44
WuXi Biologics' WuXiUP™ Accomplishes Automated Continuous Drug Substance Production at Pilot-Scale 2025-08-12 17:00
Intas & Accord signs Agreement to acquire Prothya Biosolutions 2025-08-11 21:41
Everest Medicines to Announce 2025 Interim Results on August 29, 2025 2025-08-11 17:11
WuXi Biologics Launches HEK 293 Stable Cell Line Platform WuXia293 Stable for Development and Manufacturing of Difficult-to-Express Molecules 2025-08-11 16:30
HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment 2025-08-11 09:00
Brain Navi Biotechnology's NaoTrac performs first surgeries in Spain 2025-08-11 09:00
RemeGen's Independently-Developed Bispecific Antibody RC148 Approved to Proceed Phase II Clinical Trial in US by FDA 2025-08-08 17:50
Codex Genetics Expands Precision Oncology Portfolio with Cxbladder Genomic Urine Tests 2025-08-08 17:45
WCC Biomedical@NACDS Total Store Expo: Advancing Microneedle Drug Delivery With WINMAP™ Platform 2025-08-08 09:30
LabConnect Partners with Kits4Life to Reduce Kit Waste and Advance Sustainable Clinical Trials 2025-08-08 00:40
XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration 2025-08-07 08:05
New revolutionary brain tech platform 'ScreenIT' puts smarter concussion care in reach 2025-08-06 06:16
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes 2025-08-05 18:40
MGI Tech Hands with Lincoln University to Revolutionize New Zealand Viticulture with Genomics 2025-08-04 18:44
Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease 2025-08-04 14:05
Alphamab Oncology Announces IND Application for Innovative PD-L1/αvβ6 Bispecific ADC JSKN022 was Officially Accepted by CDE 2025-08-04 09:28
Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics 2025-08-04 08:00
Alphamab Oncology Announces Anti-HER2 Biparatopic ADC JSKN003 Received U.S. FDA IND Approval to Initiate a Phase II Clinical Study for Platinum-Resistant Ovarian Cancer 2025-07-31 18:36
1 11 12 13 14 15 264